Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

NCT05522660 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

180

Enrollment

NETWORK

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Melanoma

Interventions

RADIATION: Stereotactic radiosurgery
DRUG: Immune checkpoint inhibitor

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]